Economic Calendar

Monday, August 31, 2009

Wall Street Stealth Lobby Defends $35 Billion Derivatives Haul

By Christine Harper, Matthew Leising and Shannon Harrington

Aug. 31 (Bloomberg) -- Wall Street is suiting up for a battle to protect one of its richest fiefdoms, the $592 trillion over-the-counter derivatives market that is facing the biggest overhaul since its creation 30 years ago.

Five U.S. commercial banks, including JPMorgan Chase & Co., Goldman Sachs Group Inc. and Bank of America Corp., are on track to earn more than $35 billion this year trading unregulated derivatives contracts. At stake is how much of that business they and other dealers will be able to keep.

“Business models of the larger dealers have such a paucity of opportunities for profit that they have to defend the last great frontier for double-digit, even triple-digit returns,” said Christopher Whalen, managing director of Torrance, California-based Institutional Risk Analytics, which analyzes banks for investors.

The Washington fight, conducted mostly behind closed doors, has been overshadowed by the noisy debate over health care. That’s fine with investment bankers, who for years quietly wielded their financial and lobbying clout on Capitol Hill to kill efforts to regulate derivatives. This time could be different. The reason: widespread public and Congressional anger over the role derivatives such as credit-default swaps played in the worst financial crisis since the Great Depression.

“Public sentiment isn’t very much in their favor,” said Richard Lindsey, a former director of market regulation at the U.S. Securities and Exchange Commission who worked at Bear Stearns Cos. from 1999 to 2006, referring to Wall Street firms. “In some places, they’re not going to have anybody who wants to listen to them.”

Bad Omen

In a bad omen for the industry, the Obama administration kept the details and timing of its plan to regulate the derivatives markets under wraps before making it public earlier this month.

Robert Pickel, head of the International Swaps and Derivatives Association, and Scott DeFife, chief lobbyist for the Securities Industry and Financial Markets Association, were meeting with Deputy Treasury Secretary Neal Wolin on Aug. 11, when Wolin mentioned that the proposals would be sent to Congress in 60 minutes, according to a person familiar with the meeting. The sudden notice was not what they were used to.

“The administration is desirous of maintaining control and the initiative on this,” said Craig Pirrong, a finance professor at the University of Houston who has testified before Congress about derivatives trading. “They wanted to make sure they could get their vision out there pure and uninfluenced by the industry.”

Big Five

The Obama proposal made public that day is an effort to gain oversight and control of the market for derivatives traded over the counter. The so-called OTC market consists of privately negotiated contracts that enable companies or investors to hedge against or bet on swings in the value of bonds, interest rates, currencies, commodities or stocks. Unlike exchanges, the business is unregulated and prices aren’t public.

The five biggest derivatives dealers in the U.S. -- JPMorgan, Goldman Sachs, Bank of America, Morgan Stanley and Citigroup Inc. -- held 95 percent of the $291 trillion in notional derivatives value of the country’s 25 largest bank holding companies at the end of the first quarter, according to a report by the Office of the Comptroller of the Currency. More than 90 percent of those derivatives were traded over the counter, the OCC data show.

Trading Revenue

In the first six months of 2009, those five banks made $35 billion from trading in both derivatives, including interest- rate and credit-default swaps, and cash instruments such as Treasuries and corporate bonds, according to company reports collected by the Federal Reserve.

About half of JPMorgan’s $31.2 billion in trading revenue from 2006 to 2008 probably came from derivatives, based on a breakdown the firm provided in a presentation in February and revenue figures in regulatory filings those years, according to Alexander Yavorsky, a senior analyst at Moody’s Investors Service in New York.

The proportion of trading revenue that comes from derivatives is similar at other top firms, according to people familiar with the banks’ income sources.

Spokespeople for all five companies declined to comment.

The Obama plan would require that the most common, or standardized, OTC derivatives be processed through clearinghouses, whose members would make good on trades in the event any of them default.

Bid-Ask Spread

The $182.5 billion federal rescue of American International Group Inc. underlined the problem of so-called counterparty risk, or the danger that one of the parties to a contract won’t be able to meet its obligations. For years New York-based AIG had run a lucrative business collecting fees by selling banks and other investors credit-default swaps, a form of insurance that would pay out if their pools of mortgage securities defaulted. When the housing market collapsed, AIG found itself unable to meet its promises and the government stepped in with taxpayer money to honor the contracts.

Wall Street expected that the administration would try to mandate clearinghouses. It didn’t anticipate the proposals would go further by requiring standardized trades be listed on exchanges or regulated platforms that entail reporting of trades, according to people familiar with how the legislation developed and who asked not to be named.

That could cost Wall Street a lot of money.

Under the current system, the banks profit from the so- called bid-ask spread, which is the gap between what they charge customers and what they pay to hedge their trades.

Interest-Rate Swaps

When a company or investor wants to enter into a swap, the bank checks internal pricing sources to determine the cost of making the opposite trade with another bank, which would enable it to eliminate any exposure on the trade. Armed with that information, it then offers a higher swap price to the client, allowing the bank to pocket a profit. The prices are measured in basis points, each of which is 0.01 percentage point.

Banks earn one to three basis points on average, each year, by creating an interest-rate swap for a customer, according to a former Deutsche Bank AG trader who asked not to be identified. For example, a bank that charges three basis points for a 10- year swap with the notional value of $100 million will earn about 23 basis points, or $230,000, over the lifetime of the trade when accounting for the present value of money, the former trader said. Banks do thousands of such deals a year.

“Part of the pull and tug is that the banks are trying to prevent more and more of the product from being commoditized in the sense of being exchange-traded,” said Charles Peabody, an analyst at Portales Partners LLC in New York, which provides institutional equity research. “Like anything that starts to get commoditized -- we’ve seen that with Trace on the bond side -- it’s obviously going to pressure margins.”

Margin Squeeze

Trace, shorthand for the Trade Reporting and Compliance Engine, was created in 2002 to post prices on all registered corporate bonds 15 minutes after trades occur. The public disclosure meant bond dealers no longer had better price data than clients, and profit margins in the business shrank by more than 50 percent, according to a Bloomberg News review of trades and a study published by the Rochester, New York-based Journal of Financial Economics.

Sanford C. Bernstein & Co. analyst Brad Hintz estimates that Wall Street revenue from trading fixed-income, commodities and currency swaps in the over-the-counter market may be reduced by 15 percent just by a move to clearinghouses. Forcing trades onto exchanges would cut revenue further.

Reducing Secrecy

Obama’s plan deals another blow to banks. It aims to discourage them and their customers from using non-standard, or customized, derivatives that can’t be processed by a clearinghouse or traded on an exchange by requiring that parties to such trades hold more capital to protect themselves against losses. The plan would also require they put up more money, known as margin, to insure they make good on the trades. Both changes would impose added costs on banks and some customers.

Regulators would get to see all of the trades in the market and the positions held by each of the participants, while the public would get data on trading volumes and open positions for the market as a whole, helping to reduce secrecy. The plan also seeks to limit sales of derivatives to individuals and small municipalities to make sure unsophisticated investors don’t get talked into contracts they don’t understand.

While the proposed Obama legislation goes further than some banks expected, it was derived from a broader plan released in June that the industry had already helped influence, said Lauren Teigland-Hunt, managing partner of Teigland-Hunt LLP, a New York law firm that represents hedge funds and institutional investors in the derivatives market.

‘Starting Point’

“They did their homework, they didn’t want to roll out something stupid,” Teigland-Hunt said of the administration. “Once they did that, they said, ‘We’re going to do this legislation. We’re not going to have it written for us.’”

The new, more detailed proposals are “a starting point,” she said. “The industry will have an opportunity to weigh in here, and will weigh in here.”

The Obama proposals don’t go as far as some people have urged. Hedge fund billionaire George Soros and Berkshire Hathaway Inc. Vice Chairman Charles Munger are among investors who have called for limits on the use of credit-default swaps. Soros wrote in a March 24 Wall Street Journal column that regulators should ban so-called naked swaps, in which the buyer isn’t protecting an existing investment.

Two days later Treasury Secretary Timothy Geithner dismissed such an idea before the House Financial Services Committee, telling members that “my own sense is that banning naked swaps is not necessary and wouldn’t help fundamentally.”

‘Overrated and Overpriced’

Janet Tavakoli, founder and president of Tavakoli Structured Finance Inc. in Chicago, said in an interview that derivatives have allowed banks to camouflage risk.

“There has been massive widespread abuse of over-the- counter derivatives, which have contributed to transactions that people knew or should have known were overrated and overpriced at the time they came to market,” said Tavakoli, who traded, structured and sold derivatives over more than two decades in the financial industry.

Wall Street is accustomed to getting its way with derivatives legislation. The last major congressional action, in 2000, was designed to exempt over-the-counter derivatives from government oversight.

Commodity Futures Act

Lawyers for Wall Street’s largest banks initiated and shepherded the 2000 Commodity Futures Modernization Act through Congress because they were concerned the business was in jeopardy from reforms proposed by Brooksley Born, then chairman of the Commodity Futures Trading Commission, according to two lawyers involved in the process who asked not to be identified.

The market has swelled more than sixfold since then, according to industry data.

“The Street does make money on this, so it tends to be pretty important to them,” said Lindsey, the former Bear Stearns executive who now works as an adviser to hedge funds and institutional investors at New York-based Callcott Group LLC.

Analysts can only estimate how much revenue the big banks make from over-the-counter derivatives because the banks provide little disclosure in their quarterly 10-Q and 10-K filings, said Portales Partners’ Peabody.

“I’ve been in the business for 30 years, and I read these 10-Qs and 10-Ks, and I still walk away not understanding how they’re conducting their business, how profitable it is,” Peabody said.

Wall Street Campaign

In recent months, Wall Street firms have embarked on a lobbying campaign to influence the media and legislators.

Goldman Sachs held an off-the-record seminar for reporters in April to explain how credit-default swaps work. Deutsche Bank has offered to put clients in touch with media to discuss concerns about increased capital and margin requirements.

JPMorgan has mobilized some corporate clients, advising them that the proposed changes could hurt their ability to hedge against losses, according to a person familiar with the matter.

The banks “are saying everyone thinks we’re biased, so you have to go out there and talk about it,” said Paul Zubulake, a senior analyst at Boston-based research and consulting firm Aite Group LLC.

While banks say the need for customized contracts stems from customer demand, it’s often the case that Wall Street pushes the products on their clients, said Lindsey, the former Bear Stearns executive.

“Some customers want bespoke derivatives, but often these products are sold, not bought,” he said.

Derivatives 101

On Aug. 24, while lawmakers were on recess, the U.S. Chamber of Commerce organized a briefing for congressional staffers aimed at explaining how companies use derivatives to manage risk. The session, called “Derivatives 101,” featured speakers from Cargill Inc. and Devon Energy Corp., so-called end-users that don’t represent banks, said Jason Matthews, who leads the group’s lobbying efforts on financial-services issues.

The organization called the briefing because “some proposals would make it very difficult for many companies, including manufacturers, energy companies and commercial real estate owners and developers to use over-the-counter derivatives to manage the risks of their day-to-day business,” Matthews said in his e-mail invitation to the staffers.

Wall Street firms and trade associations have held a series of meetings with staff members of the House Financial Services Committee to discuss derivatives trading, said Cory Strupp, who ran government relations for JPMorgan before joining SIFMA, the securities-industry group, last year.

Defining ‘Standardized’

“There’s been a big learning curve, and members and staff have gone a long way along that curve,” said Strupp, a key lobbyist on derivatives. Strupp was on the team at JPMorgan a decade ago when the industry persuaded Congress to repeal the depression-era Glass-Steagall law that separated deposit-taking companies from investment banks.

While the Obama proposals will have “a lot of influence,” they won’t necessarily serve as a “base text” for legislation, Strupp said.

Wall Street firms stand to benefit from staving off efforts for reform. One senior executive at a top-five derivatives firm, who declined to comment publicly, said that while he expects Congress will adopt some form of legislation, he thinks it will be a long time coming and that the degree of reform is in doubt.

One key issue is how the government and regulators define the word “standardized,” which will determine what contracts need to be handled by clearinghouses and can be traded on exchanges.

“The legislation would say that all standardized contracts need to be cleared, which begs the question what is standardized?” said Geoffrey Goldman, a partner who focuses on derivatives and structured products at law firm Shearman & Sterling in New York. “The bill doesn’t answer that question.”

Schapiro, Gensler

That question, which will determine how much change there is in the way the contracts are traded, may fall to regulators, including SEC chairman Mary Schapiro and Gary Gensler, chairman of the Commodity Futures Trading Commission, Goldman said.

In interviews last week, both Schapiro and Gensler said there was a need to make the OTC derivatives market more transparent and less risky by moving more trading onto exchanges and clearinghouses.

“I feel passionately that we must bring the over-the- counter derivatives marketplace under regulation,” said Gensler, a former Goldman Sachs banker who opposed giving the CFTC oversight of over-the-counter derivatives when he worked at the Treasury Department from 1997 to 2001. “Looking back, there’s no doubt that I think all of us should have done more to protect the American public knowing what we know now.”

ICE, CME

Another debate is over which clearing platforms or exchanges should be used. JPMorgan, Goldman Sachs, Bank of America, Citigroup, Morgan Stanley and other banks will begin sharing profits next year from the credit-default swap clearinghouse ICE US Trust LLC.

While the banks have an interest in supporting that initiative, they’re expected to lobby to remove any requirements that the contracts be executed on exchanges because that would cut them out of making a profit on the trades, according to lawyers working for the banks.

“The broker-dealers are happy to clear as much as they can because they do have a vested interest in the clearing companies that they’re clearing these products through,” said Aite Group’s Zubulake.

Chicago-based CME Group Inc., the world’s largest futures exchange, would be a logical place to clear interest-rate swaps because it already clears Eurodollar futures, which are often used as a hedge for rate swaps, Zubulake said. He doubts that will happen though.

“They don’t want to clear an interest-rate swap through the CME because they don’t own the CME,” Zubulake said.

Delaying Reform

Paul Gulberg, a colleague of Peabody’s at Portales Partners, said the most likely outcome is legislation requiring that trades be reported and, in some cases, cleared. He said it’s “not very likely” the law will force derivatives onto an exchange or an electronic facility.

Health-care reform may make it unlikely any derivatives legislation will be enacted in the near future, Peabody said.

For Wall Street, the longer it takes to get legislation passed the better. As stock market values and the economy improve, anger at banks is likely to subside.

“If we don’t pass it by early 2010, we get into the congressional election period where this is just too controversial an issue,” Peabody said. “You’ve got too many different financial interests with opposing views that Congress just isn’t going to go out on a limb and pass it and put their re-election in jeopardy. We don’t think we’re going to see legislation until 2011.”

To contact the reporters on this story: Christine Harper in New York at charper@bloomberg.net; Matthew Leising in New York at mleising@bloomberg.net; Shannon D. Harrington in New York at sharrington6@bloomberg.net.





Read more...

Cerberus to Raise New Funds After Investors Pull $4.77 Billion

By Katherine Burton

Aug. 31 (Bloomberg) -- Cerberus Capital Management LP plans to raise money in the fourth quarter to buy distressed companies and securities after losses on investments such as Chrysler LLC and GMAC LLC led to $4.77 billion in client redemptions.

The withdrawal requests, representing 60 percent of the $7.9 billion in its Cerberus Partners LP and Cerberus Institutional LP funds, came mostly from other managers who need to pay off investors, according to Mark Neporent, the New York- based firm’s chief operating officer and general counsel. Institutions and wealthy individuals are still looking to invest with Cerberus, which oversees $24.3 billion, including a $1 billion fund raised last month, he said.

“These redemptions are not a reflection of a lack of confidence, but a reflection of demands of liquidity” from the funds of funds that had placed clients’ cash with Cerberus, Neporent said in an Aug. 29 interview.

Cerberus, founded in 1992 by former Drexel Burnham Lambert Inc. banker Stephen Feinberg, stayed out of the limelight as it focused on buying troubled companies, debt and real estate. It stumbled with its two highest-profile deals: leading separate groups that invested almost $15 billion combined for controlling stakes in automaker Chrysler and GMAC, the former finance arm of General Motors Co.

The firm wrote off the majority of its Chrysler stake as the Auburn Hills, Michigan-based company headed into a U.S. government-orchestrated bankruptcy. Its stake in GMAC was diluted when the Detroit-based lender was bailed out by the U.S. and converted into a bank holding company. They were rare mistakes for Feinberg, 49, whose firm has generated average annual returns of about 20 percent since its inception, according to Neporent.

‘Embarrassed and Disappointed’

“We are embarrassed and disappointed by our 2008 performance, and we feel a huge obligation to you to turn this around,” Feinberg wrote in July 3 letter to clients.

Cerberus manages $19.6 billion in distressed funds that generally buy the same assets, including corporate bonds, bank loans and private companies, according to Neporent, 52. It also runs real estate and lending funds.

Neporent said the new funds will target distressed assets. He declined to provide details, including how much money the firm is seeking to raise.

Cerberus Partners and Cerberus International lost more than 20 percent last year and largely stopped making investments in the fourth quarter, Neporent said. The funds, which capped withdrawals in December, are little changed this year while the firm’s other distressed funds have gained 18 percent.

Choice for Investors

The funds had permitted redemptions semiannually with six months’ notice, which is in line with many hedge funds. Its other funds have four-year lock-ups and trade out of their investments over six to eight years, which is similar to buyout firms.

“We’ve never viewed ourselves as a traditional private- equity fund,” Neporent said. The fund that was completed in July has a four-year lock-up.

Cerberus, named after the mythical three-headed dog that guards the gates of hell, asked clients of the funds that suspended redemptions in July whether they wanted to continue their investment with a lower fee. Those who wanted to withdraw would have to wait for assets to be liquidated before getting back all their money, a process that could take as long as four years.

The firm’s partners hold about 15 percent of the funds, or $1.18 billion, and aren’t withdrawing, Neporent said. Investors with more than 70 percent of the remaining assets said they wanted out.

Fee Waiver

Clients of the suspended funds who want Cerberus to continue to manage their money won’t pay performance fees, typically 20 percent of profits, until their losses are recouped, Neporent said. After that, Cerberus will lower the performance fees for a period of time that hasn’t been made final.

Clients who want to withdraw will be shifted into a separate fund that will return cash as assets are sold. Cerberus will take an annual management fee of 0.5 percent of assets, according to an Aug. 27 letter to investors.

These investors may get about 5 percent of their money back soon after Cerberus sets final terms of the agreement, Neporent said.

It could take three or four years for the assets to be sold and all the money returned, depending on market conditions, Neporent said. The firm will be patient and won’t liquidate at fire-sale prices.

“We will sell only when we think it makes sense,” he said.

To contact the reporter on this story: Katherine Burton in New York at kburton@bloomberg.net.





Read more...

Inflation Will Accelerate This Decade, Business Economists Say

By Carlos Torres

Aug. 31 (Bloomberg) -- The Federal Reserve will be unable to prevent the trillions of dollars in government stimulus pumped into the U.S. economy from stoking inflation later this decade, a survey of business economists showed.

The price gauge tracked by the central bank will rise 3 percent a year on average from 2014 through 2018, according to the median estimate in a poll taken by the National Association for Business Economics. The rate exceeds the 2 percent pace that the respondents said was the Fed’s unofficial target.

The report is in line with surveys of consumers and indicates the central bank may have to work harder to damp inflation expectations after pouring more than $1 trillion into credit markets in a strategy known as quantitative easing. Economists in the survey also said the Obama administration’s $787 billion stimulus program would push consumer prices higher.

“An excessively stimulative fiscal policy and a complicated exit from its quantitative easing policies over the medium term will result in the Fed tolerating a higher level of inflation than it desires,” according to a statement issued by the Washington-based group today.

The price measure that tracks consumer spending and excludes food and fuel costs, the Fed’s favorite, rose 1.4 percent in July from the same month last year, the smallest gain since 2003, a Commerce Department report showed last week. The last time it exceeded 3 percent was in 1992.

Inflation Concerns

The main reasons cited for concern over the inflation outlook included “lagged effects of policies now in effect,” “monetization of the debt” and an “ineffective exit strategy” by the central bank, the report said. Only a “small percentage” thought a loss of Fed independence will cause prices to accelerate.

American consumers projected this month that inflation will rise 2.8 percent per year over the next five years, according to the Reuters/University of Michigan sentiment survey issued last week.

Fifty-six percent of the economists in the NABE survey said the Fed will keep the benchmark interest rate target near zero for at least the next six months, while 44 percent projected it would rise.

Half of those surveyed thought the government’s fiscal measures were excessive, up from 33 percent in the group’s March survey. Almost eight out of every 10 economists surveyed said a second stimulus bill wasn’t needed.

Less Spending

Three-quarters said they would like to see the government cut spending over the next two years, while only 28 percent projected the reductions would actually take place.

The economists also favored increased regulation of financial markets, including greater oversight of derivatives, requirements on financial institutions to put more of their own funds at stake when securitizing mortgages and reform of the credit-rating companies.

This was the most surprising finding for Chris Varvares, the president of NABE and of Macroeconomic Advisers LLC in St. Louis.

“This tends to be a fairly conservative group, and you can see it except when it comes to regulation,” Varvares said in an interview. “They definitely are into more regulation in financial services.”

To contact the reporter on this story: Carlos Torres in Washington at ctorres2@bloomberg.net





Read more...

Yen Rises on Stock Losses, Exporters’ Purchases, Election Win

By Ron Harui

Aug. 31 (Bloomberg) -- The yen rose to a five-week high against the euro as declines in Asian stocks spurred investors to sell higher-yielding assets and on speculation Japanese exporters bought the currency on the last day of the month.

Japan’s currency gained versus all 16 major counterparts after the opposition Democratic Party of Japan swept to power in elections yesterday. The yen climbed to a seven-week high versus the dollar as falling profits at Chinese companies pushed the benchmark Shanghai index down the most in 9 months, boosting demand for Japan’s currency as a refuge.

“The slide in China’s equity markets led to buying of the yen,” said Toshihiko Sakai, head of trading for foreign exchange and financial products at Mitsubishi UFJ Trust & Banking Corp. in Tokyo. “Investors are still risk averse as they believe the stock rally is excessive as compared with corporate earnings.”

The yen climbed to 132.26 per euro as of 7:35 a.m. in London from 133.85 in New York on Aug. 28. It earlier reached 132.19, the highest level since July 22. The Japanese currency advanced to 92.75 per dollar from 93.60, after touching 92.55, the strongest level since July 13.

The euro fell to $1.4260 from $1.4303 in New York on Aug. 28. The currency bought 87.98 British pence from 87.89 pence, after advancing to 88.39 pence on Aug. 27, the highest level since June 5.

Chinese Stocks Fall

Japan’s currency was set for a monthly advance versus 10 major Asian currencies on concern investors may trim holdings of emerging-market assets. The Shanghai Composite Index fell 6.2 percent today, the most since November 2008. The Nikkei 225 Stock Average declined 0.4 percent and the MSCI Asia-Pacific Index of regional shares lost 0.6 percent.

China Southern Airlines Co., the nation’s largest carrier, said yesterday that first-half net income tumbled 97 percent. Baoshan Iron & Steel Co., China’s biggest steelmaker, said on Aug. 28 that first-half profit plunged 93 percent, while China Merchants Bank Co. on the same day posted its third consecutive quarter of declining profits.

The yen also gained after public broadcaster NHK said the DPJ captured 308 of the 480 lower-house seats, prompting speculation foreign investors will put more money into the world’s second-largest economy.

DPJ President Yukio Hatoyama and his party have pledged to boost child-care spending, cut taxes and curtail the power of bureaucrats after they ended the rule of Prime Minister Taro Aso’s Liberal Democratic Party.

‘Stashed the Cash’

“What appeals to me on the Japan call is that these are the voters who have stashed the cash under the beds,” Tom Murphy, managing partner in Sydney at Family Office Research & Management Ltd., said in a Bloomberg Television interview. “If we get just some increase in investment from the elderly within the population into growth assets of some type, we could see quite a change.”

The yen also climbed amid speculation Japanese exporters purchased the nation’s currency.

“Exporters possibly bought the yen because of month-end demand,” said Lee Wai Tuck, a currency strategist at Forecast Pte in Singapore.

Japanese companies forecast the yen would average 94.85 per dollar in the 12 months to March 2010, according to the Bank of Japan’s quarterly Tankan survey released July 1.

The euro is poised for its first back-to-back monthly climb versus the dollar since March 2008 before a German report tomorrow estimated to show retail sales in Europe’s largest economy rose for the first time in three months.

German Retail Sales

Sales, adjusted for inflation and seasonal swings, climbed 0.7 percent in July, after a 1.3 percent drop in June, a Bloomberg survey of economists showed before the Federal Statistics Office’s report in Wiesbaden. An index of executive and consumer sentiment in the 16-nation region increased to 80.6, the highest since October, from 76 in July, the European Commission in Brussels said on Aug. 28.

“Recent data have exceeded economists’ predictions, suggesting the euro-zone economy is on a gradual recovery path,” said Yoh Nihei, trading group manager at Tokai Tokyo Securities Co. in Tokyo. “The trend is for the euro to strengthen.”

Europe’s single currency may reach $1.4500 this week, Nihei said.

The European Central Bank will keep its main refinancing rate at 1 percent at its Sept. 3 meeting, according to all 58 analysts surveyed by Bloomberg.

New Zealand’s Dollar

New Zealand’s dollar fell for a second day versus its U.S. counterpart as the country’s central bank Governor Alan Bollard said in a radio interview the currency’s strength is hampering an export-led recovery.

Foreign-exchange traders are increasing bets that Bollard will abandon his pledge to keep interest rates at a record low. New Zealand’s dollar appreciated 3.1 percent this month versus the U.S. dollar on speculation the central bank may raise borrowing costs as soon as March following gains in consumer spending and house prices.

“New Zealand may surprise people as one of the first central banks to tighten,” said David Tien, a money manager at Fischer Francis Trees & Watts in New York, with $19 billion in assets. “If global activities pick up, Asia is best positioned. New Zealand rates should normalize.”

The currency known as the kiwi fell 0.4 percent at 68.17 U.S. cents.

To contact the reporters on this story: Ron Harui in Singapore at rharui@bloomberg.net.





Read more...

Yen Rises on Stock Losses, Exporters’ Purchases, Election Win

By Ron Harui

Aug. 31 (Bloomberg) -- The yen rose to a five-week high against the euro as declines in Asian stocks spurred investors to sell higher-yielding assets and on speculation Japanese exporters bought the currency on the last day of the month.

Japan’s currency gained versus all 16 major counterparts after the opposition Democratic Party of Japan swept to power in elections yesterday. The yen climbed to a seven-week high versus the dollar as falling profits at Chinese companies pushed the benchmark Shanghai index down the most in 9 months, boosting demand for Japan’s currency as a refuge.

“The slide in China’s equity markets led to buying of the yen,” said Toshihiko Sakai, head of trading for foreign exchange and financial products at Mitsubishi UFJ Trust & Banking Corp. in Tokyo. “Investors are still risk averse as they believe the stock rally is excessive as compared with corporate earnings.”

The yen climbed to 132.26 per euro as of 7:35 a.m. in London from 133.85 in New York on Aug. 28. It earlier reached 132.19, the highest level since July 22. The Japanese currency advanced to 92.75 per dollar from 93.60, after touching 92.55, the strongest level since July 13.

The euro fell to $1.4260 from $1.4303 in New York on Aug. 28. The currency bought 87.98 British pence from 87.89 pence, after advancing to 88.39 pence on Aug. 27, the highest level since June 5.

Chinese Stocks Fall

Japan’s currency was set for a monthly advance versus 10 major Asian currencies on concern investors may trim holdings of emerging-market assets. The Shanghai Composite Index fell 6.2 percent today, the most since November 2008. The Nikkei 225 Stock Average declined 0.4 percent and the MSCI Asia-Pacific Index of regional shares lost 0.6 percent.

China Southern Airlines Co., the nation’s largest carrier, said yesterday that first-half net income tumbled 97 percent. Baoshan Iron & Steel Co., China’s biggest steelmaker, said on Aug. 28 that first-half profit plunged 93 percent, while China Merchants Bank Co. on the same day posted its third consecutive quarter of declining profits.

The yen also gained after public broadcaster NHK said the DPJ captured 308 of the 480 lower-house seats, prompting speculation foreign investors will put more money into the world’s second-largest economy.

DPJ President Yukio Hatoyama and his party have pledged to boost child-care spending, cut taxes and curtail the power of bureaucrats after they ended the rule of Prime Minister Taro Aso’s Liberal Democratic Party.

‘Stashed the Cash’

“What appeals to me on the Japan call is that these are the voters who have stashed the cash under the beds,” Tom Murphy, managing partner in Sydney at Family Office Research & Management Ltd., said in a Bloomberg Television interview. “If we get just some increase in investment from the elderly within the population into growth assets of some type, we could see quite a change.”

The yen also climbed amid speculation Japanese exporters purchased the nation’s currency.

“Exporters possibly bought the yen because of month-end demand,” said Lee Wai Tuck, a currency strategist at Forecast Pte in Singapore.

Japanese companies forecast the yen would average 94.85 per dollar in the 12 months to March 2010, according to the Bank of Japan’s quarterly Tankan survey released July 1.

The euro is poised for its first back-to-back monthly climb versus the dollar since March 2008 before a German report tomorrow estimated to show retail sales in Europe’s largest economy rose for the first time in three months.

German Retail Sales

Sales, adjusted for inflation and seasonal swings, climbed 0.7 percent in July, after a 1.3 percent drop in June, a Bloomberg survey of economists showed before the Federal Statistics Office’s report in Wiesbaden. An index of executive and consumer sentiment in the 16-nation region increased to 80.6, the highest since October, from 76 in July, the European Commission in Brussels said on Aug. 28.

“Recent data have exceeded economists’ predictions, suggesting the euro-zone economy is on a gradual recovery path,” said Yoh Nihei, trading group manager at Tokai Tokyo Securities Co. in Tokyo. “The trend is for the euro to strengthen.”

Europe’s single currency may reach $1.4500 this week, Nihei said.

The European Central Bank will keep its main refinancing rate at 1 percent at its Sept. 3 meeting, according to all 58 analysts surveyed by Bloomberg.

New Zealand’s Dollar

New Zealand’s dollar fell for a second day versus its U.S. counterpart as the country’s central bank Governor Alan Bollard said in a radio interview the currency’s strength is hampering an export-led recovery.

Foreign-exchange traders are increasing bets that Bollard will abandon his pledge to keep interest rates at a record low. New Zealand’s dollar appreciated 3.1 percent this month versus the U.S. dollar on speculation the central bank may raise borrowing costs as soon as March following gains in consumer spending and house prices.

“New Zealand may surprise people as one of the first central banks to tighten,” said David Tien, a money manager at Fischer Francis Trees & Watts in New York, with $19 billion in assets. “If global activities pick up, Asia is best positioned. New Zealand rates should normalize.”

The currency known as the kiwi fell 0.4 percent at 68.17 U.S. cents.

To contact the reporters on this story: Ron Harui in Singapore at rharui@bloomberg.net.





Read more...

Corn Falls for Third Month as U.S. Crop Production May Increase

By Jae Hur

Aug. 31 (Bloomberg) -- Corn was poised for a third monthly decline on speculation the U.S. crop condition may improve, paving the way for increased production. Soybeans also fell.

The U.S. Department of Agriculture is to issue its weekly crop condition report after Chicago trading closes today. About 70 percent of the corn crop was in good or excellent condition on Aug. 23, up from 68 percent a week earlier, the USDA said last week.

“We may see a further increase in the weekly USDA corn crop ratings later today,” Toshimitsu Kawanabe, an analyst at Tokyo-based commodity broker Central Shoji Co., said. “It will be a bumper harvest.”

Corn for December delivery fell 0.6 percent to $3.27 a bushel at 11:48 a.m. Singapore time after trading between $3.265 and $3.32 in electronic trading on the Chicago Board of Trade. The contract touched $3.115 on Aug. 17, the lowest in more than eight months.

The grain has lost 6.4 percent this month, after declining 20 percent during the previous two months on cool temperatures and abundant soil moisture. The USDA has predicted a crop of 12.761 billion bushels, 5.5 percent more than last year and the second-largest ever.

“Record-high yield expectations for the U.S. 2009 crop mean the corn market will require substantial stimulus from the demand-side if we are to see any sustained rallies,” said Toby Hassall, a research analyst at CWA Global Markets Pty in Sydney.

Mexico, the world’s second-biggest corn buyer, may boost imports of the grain to a record as dry weather harms crops in central and northern regions, according to the president of the National Confederation of Farmers.

Mexico Imports

Mexico, where corn is a staple used in tortillas and hot drinks, may import 12 million metric tons of yellow corn this year, Cruz Lopez Aguilar, president of the Mexico City-based body, said Aug. 28. The USDA estimates Mexico will import 9 million tons of corn in the 12 months starting Oct. 1, up from 7.4 million tons in the current marketing year.

Soybeans for November delivery fell as much as 1.5 percent to $9.955 a bushel and were at $9.975 as of 12 p.m. Singapore time. The most-active contract rose 3.9 percent last week, the first gain in three weeks, on concern that the slow pace of plant growth may increase the risk of damage from an early Midwest freeze in the U.S.

‘Dwindling’ Supplies

The neaby September contract jumped 11 percent last week “thanks to anxiety over dwindling old-crop supplies combined with a robust demand profile,” Hassall said. “Given the late- maturing U.S. crop will be more at risk to late-season weather events, the market will retain a palpable sense of anxiety until U.S. new-crop beans hit the bins.”

Wheat for December delivery dropped 0.6 percent at $4.9225 a bushel as of 11:58 a.m. Singapore time after trading between $4.9175 and $4.99. The price gained 1.6 percent last week, the first increase since July.

The contract has dropped 6.8 percent this month, the third monthly loss. World production will total 662 million tons, the International Grains Council said Aug. 27, up from 654 million tons forecast in July.

To contact the reporter on this story: Jae Hur in Singapore at jhur1@bloomberg.net





Read more...

Gold Climbs a Fifth Day as Dollar Drops on Signs of Recovery

By Kim Kyoungwha

Aug. 31 (Bloomberg) -- Gold rose for a fifth day, the longest run of increases in more than a month, as the dollar weakened on signs a recovery in global economies may be accelerating.

Bullion climbed as positive economic data weakened demand for the U.S. currency, driving the Dollar Index lower. An Institute of Supply Management report due tomorrow in the U.S. may show manufacturing expanded for the first in 19 months, according to a survey of economists.

“There are some signs that demand for jewelry is reviving, helped by a rebound in global economies,” said Chris Yu, head of trading with Samsung Futures Co. in Seoul. “The dollar’s weakness is also lending support to commodities, including gold.”

Gold for immediate delivery rose as much as 0.6 percent to $960.75 an ounce and last traded at $955.61 at 1:46 p.m. in Singapore. The precious metal has advanced 8.4 percent this year. The dollar weakened to 92.76 against the yen and Dollar Index was little changed after dropping as much as 0.3 percent earlier.

Hedge-fund managers and other large speculators increased net-long position in New York gold futures in the week ended Aug. 25, according to U.S. Commodity Futures Trading Commission data.

Speculative long positions, or bets prices will rise, outnumbered short positions by 182,982 contracts on the Comex division of the New York Mercantile Exchange, the Washington based commission said in its Commitments of Traders report. Net long positions rose by 5,452 contracts, or 3 percent, from a week earlier.

Gold holdings in the SPDR Gold Trust, the biggest exchange traded fund backed by bullion, were unchanged for a third day as of Aug. 28 at 1,061.83 metric tons, the lowest since March 13, according to figures on the company’s Web site. The net asset value of the Trust was $32.6 billion.

Among other precious metals for immediate delivery, silver slipped 0.3 percent to $14.69 an ounce, platinum advanced 0.3 percent to $1,246 an ounce and palladium gained 0.4 percent to $289.50 an ounce at 1:53 p.m. in Singapore.

To contact the reporter on this story: Kyoungwha Kim in Singapore at Kkim19@bloomberg.net





Read more...

Australian Farmer Confidence Rises on Winter Rain, Bank Says

By Madelene Pearson

Aug. 31 (Bloomberg) -- Confidence among farmers in Australia, the world’s fourth-largest wheat shipper and third- largest canola exporter, grew for a second quarter, driven by rainfall in early winter, Rabobank Groep NV said.

The number of farmers who expect conditions to improve in the coming year climbed to 28 percent, up from 20 percent in the previous quarter, the bank, the world’s largest agricultural lender, said today, citing its latest Rural Confidence Survey. The number of farmers expecting conditions to worsen decreased to 25 percent, from 37 percent, it said in an e-mailed statement.

Australian farmers are waiting on rain needed to finish winter crops including wheat, barley and canola before the harvest starts in about November. Rabobank has predicted Australia’s wheat crop at 22.8 million metric tons, up from last year’s 21.4 million tons.

“Producers are now eagerly awaiting more rain to finish off what is shaping up as a good winter cropping season for many areas,” Peter Knoblanche, Rabobank general manager Rural Australia, said in the statement. “For many winter crop producers, the amount of rain needed to finish the crop was only modest and may be achieved despite possible generally drier conditions.”

The El Nino weather phenomenon, which can cause drought in the country, is developing, Australia’s weather bureau has said. The possible return of El Nino has caused concern and some caution among producers, Rabobank said.

Wheat futures for December delivery rose as much as 0.8 percent to $4.9650 on the Chicago Board of Trade in after-hours electronic trading at 11:42 a.m. in Sydney. The commodity has lost 38 percent in the past year.

To contact the reporter on this story: Madelene Pearson in Melbourne on mpearson1@bloomberg.net





Read more...

Zinc Falls to One-Week Low in Shanghai After Inventory Expands

By Bloomberg News

Aug. 31 (Bloomberg) -- Zinc fell to the lowest in more than a week in Shanghai as expanding inventory raised speculation supply may outpace demand for the metal used to galvanize steel.

Zinc stockpiles monitored by the Shanghai Futures Exchange climbed by 1.8 percent to 117,499 metric tons last week, the highest since introduction of the contract in 2007, according to exchange data. China’s cabinet said last week it’s studying curbs on overcapacity in industries including steel and cement as policy makers seek to rein in investment growth fueled by a record credit expansion this year.

“Investors and producers are turning cautious due to signs of weaker fundamentals and have stepped up selling,” said Zeng Qianling, an analyst at Jinrui Futures Co. from Shenzhen today.

Zinc for December delivery on the Shanghai exchange slumped as much as 2.2 percent to 15,000 yuan ($2,196) a ton, the lowest since Aug. 21, and last traded at 15,050 yuan.

Shanghai copper declined as much as 1.8 percent to 49,800 yuan a ton after climbing as much as 1.2 percent earlier to the highest since September 2008. Shanghai aluminum slid as much as 0.9 percent to 14,900 yuan a ton.

The London Metal Exchange is closed today for the summer bank holiday.

--Li Xiaowei. Editors: Richard Dobson, Wendy Pugh.

To contact the Bloomberg News staff on this story: Li Xiaowei in Shanghai at Xli12@bloomberg.net





Read more...

Yen Strengthens, Japanese Stocks Drop as DPJ Sweeps to Power

By Masaki Kondo

Aug. 31 (Bloomberg) -- The yen strengthened after the Democratic Party of Japan won yesterday’s national election by a landslide, marking an end to single-party government that lasted almost unbroken for half a century. Japanese exporters of cars and electronics declined in stock trading.

The yen appreciated to 132.42 per euro in Tokyo from 133.85 in New York on Aug. 28, and strengthened to 92.72 per dollar from 93.60. The Nikkei 225 Stock Average fell 0.4 percent to 10,492.53 at the 3 p.m. close on the Tokyo Stock Exchange, reversing an earlier gain of 2.2 percent. Bonds rose.

“Some are saying the market has fully reflected the change of government, but the change is too big to be priced in,” said Hisakazu Amano, who helps oversee the equivalent of $18 billion at T&D Asset Management Co. “The impact of the DPJ victory on company earnings is still uncertain and investors can’t decide what to buy or sell.”

The DPJ routed the Liberal Democratic Party in yesterday’s vote, capturing 308 of 480 lower-house seats, national broadcaster NHK said. The DPJ has pledged to revive an economy emerging from its deepest recession since World War II by boosting child-care spending, cutting taxes and limiting the power of bureaucrats.

To contact the reporter for this story: Masaki Kondo in Tokyo at mkondo3@bloomberg.net.





Read more...

Asian Stocks Decline on Lower China Earnings, Strengthening Yen

By Patrick Rial and Shani Raja

Aug. 31 (Bloomberg) -- Asian stocks fell, led by mining companies and Japanese exporters, as Chinese companies reported lower profit and the Democratic Party of Japan’s election victory drove the yen higher.

Baoshan Iron & Steel Co. fell 7 percent in Shanghai after first-half profit plunged 93 percent. China Merchants Bank Co. fell 6.3 percent amid plans to increase the size of a rights offer. Canon Inc., which gets 28 percent of its revenue from the Americas, sank 3.3 percent. Japan’s currency gained versus all 16 major counterparts after public broadcaster NHK said the DPJ captured at least 308 of the 480 lower-house seats.

The MSCI Asia Pacific Index lost 0.6 percent to 113.28 as of 3:30 p.m. in Tokyo. The gauge has surged 60 percent from a more than five-year low on March 9 on speculation the global economy is recovering. That’s taken the average price of stocks on the index to 1.5 times book value, close to an 11-month high.

“Stocks have rallied a long way and are technically overbought,” said Nader Naeimi, a Sydney-based strategist at AMP Capital Investors, which manages about $75 billion. “We probably need a good correction ahead of the next jump.”

The Shanghai Composite Index slumped 6.2 percent. Industrial Bank Co. slumped 9 percent after Caijing magazine reported that the nation’s banks may have cut new loan growth.

Hong Kong’s Hang Seng Index dropped 1.8 percent, led by China Petroleum & Chemical Corp., which fell 3.9 percent on concern the government will keep fuel prices unchanged to support the economy as crude climbs, squeezing margins.

ANZ Bank, Ibiden

Among stocks that rose today, Australia & New Zealand Banking Group Ltd. jumped 4.1 percent after saying profit rose. Ibiden Co., which supplies printed circuit boards to Intel Corp., climbed 4.4 percent in Tokyo after the U.S. company boosted its sales forecast.

Futures on the U.S. Standard & Poor’s Index fell 0.6 percent. The gauge dropped 0.2 percent on Aug. 28.

Japan’s Nikkei 225 Stock Average lost 0.3 percent, reversing an earlier 2.2 percent climb. Government reports showed factory output rose at the slowest pace in four months in July and retail sales fell, underscoring the challenge for the incoming government to sustain an economic recovery.

The DPJ routed the Liberal Democratic Party in Japan’s national elections, capturing 308 of 480 lower-house seats, national broadcaster NHK said. The DPJ has pledged to revive an economy emerging from its deepest recession since World War II by boosting child-care spending, cutting taxes and limiting the power of bureaucrats.

Worst Performing Index

The Shanghai Composite Index has fallen 21 percent in the past month, making it the world’s worst performing major stock index in that time, as banks reined in lending to avert asset bubbles and policy makers advised industries such as steel and cement to curb overcapacity.

Baoshan Iron fell 7 percent to 6.42 yuan. The company said the “global economy hasn’t recovered substantially and the foundations for a domestic recovery aren’t solid,” threatening prospects for the steel industry.

The rally in Asian stocks since March has been driven in part by profit reports in the past month that have exceeded analyst estimates. Some 35 percent of the 620 companies in the MSCI Asia Pacific Index that have reported net income since early July have beaten analyst predictions, while about 21 percent have missed, according to data compiled by Bloomberg.

China Merchants Bank, the nation’s fifth-biggest by market value, dropped 6.3 percent to 13.62 yuan. The lender posted its third consecutive quarter of declining profits as loan margins contracted and it set aside additional funds for loan defaults.

The Shenzhen-based bank said it will increase the amount raised from its planned rights offer by as much as 22 percent.

Slowing Loan Growth

Industrial Bank, which reported a 4.9 percent decline in first-half profit on Aug. 24, slumped 9 percent to 28.19 yuan.

China may have 200 billion yuan of new loans in August, the Beijing-based Caijing magazine reported today on its Web site. That compares with 355.9 billion yuan in new loans in July and 1.53 trillion yuan in June.

“The local market bears are convinced that tightening is already underway,” said Howard Wang, head of the Greater China team at JF Asset Management, which oversees $50 billion. “Sentiment only can change with either a very strong set of macro numbers in August, laying to rest that tightening will ‘break’ the recovery, or stronger statements from central authorities.”

China Petroleum slumped 3.9 percent to HK$6.41, while PetroChina Co., the world’s most valuable company, sank 1.9 percent to HK$8.64. The government will reduce the number of times it adjusts fuel prices at this “critical juncture” for the economy, the state-run Shanghai Securities News reported Aug. 29.

Stronger Yen

In Tokyo, Canon, which makes digital cameras, sank 3.3 percent to 3,570 yen on concern a stronger yen will hurt the value of overseas sales when repatriated back into the local currency. Honda Motor Co., which gets more than half its sales in North America, dropped 1.8 percent to 2,935 yen.

The yen appreciated to 132.68 per euro following the election results from 133.85 in New York on Aug. 28. The Japanese currency strengthened to 92.77 per dollar from 93.60.

“Some are saying the market has fully reflected the change of government, but the change is too big to be priced in,” said Hisakazu Amano, who helps oversee the equivalent of $18 billion at T&D Asset Management Co. “The impact of the DPJ victory on company earnings is still uncertain and investors can’t decide what to buy or sell.”

ANZ Bank, Australia’s fourth-biggest bank, jumped 4.1 percent to A$21.29. The company said profit in the 10 months ended July climbed from the same period a year earlier after lending grew and bad debts were lower than internal estimates.

Ibiden surged 4.4 percent to 3,310 yen. Rival Shinko Electric Industries Co. rallied 1.5 percent to 1,736 yen.

Intel, the world’s biggest chipmaker, said on Aug. 28 that third-quarter sales will be at least $8.8 billion, compared with at least $8.1 billion projected last month. The stock jumped 4 percent in New York on Aug. 28.

To contact the reporter for this story: Patrick Rial in Tokyo at prial@bloomberg.net; Shani Raja in Sydney at sraja4@bloomberg.net.





Read more...

Citigroup Lifts Price Target for VW Preferred Stock, Cuts Common

By Christiane Lenzner

Aug. 31 (Bloomberg) -- Citigroup Inc. raised its price estimate for Volkswagen AG’s preferred shares to 80 euros from 45 euros, while cutting its projection for the common stock to 120 euros from 200 euros.

The preferred shares “are effectively the only practical investment route into the European, and possibly global car leader, with index inclusion inevitable we believe, though not before December unless Qatar exercises early.”

The brokerage lifted its share-price estimate for Porsche SE to 45 euros from 40 euros.





Read more...

Eurofins, GDF, L’Oreal, Sanofi, Wendel: French Stocks Preview

By Anne-Sylvaine Chassany and Francesca Cinelli

Aug. 31 (Bloomberg) -- The following is a list of companies whose stocks may have unusual changes in Paris. Symbols are in parentheses after company names and prices are from the last close.

France’s CAC 40 Index advanced 44.61, or 1.2 percent, to 3,693.14, taking its weekly gain to 2.1 percent. The SBF 120 Index rose 1.2 percent to 2,687.10.

Altran SA (ALT FP): The French provider of temporary engineering-project workers for Airbus SAS said it had a first- half net loss of 30.2 million euros ($43 million), compared with a year-earlier profit of 6.9 million. The shares added 6.5 cents, or 2.4 percent, to 2.74 euros.

Carrefour SA (CA FP): Bank of America Corp. increased its share-price estimate for Europe’s biggest retailer to 34 euros from 32 euros. The brokerage kept a “neutral” recommendation. The shares rose 1.45 euros, or 4.6 percent, to 33.1 euros.

Eurofins Scientific SA (ERF FP): The French-listed provider of quality testing for wine and drugmakers posted a first-half loss of 3.4 million euros, compared with a 3.1 million-euro profit a year earlier. The company said it can’t make predictions for the next six months. The shares fell 10 cents, or 0.3 percent, to 39.2 euros.

European Aeronautic Defence & Space Co. (EAD FP): The European Union signaled governments will proceed with subsidies for EADS’s Airbus SAS A350 even if a pending World Trade Organization decision finds previous aid to the biggest planemaker was illegal. The shares added 50 cents, or 3.5 percent, at 14.73 euros.

GDF Suez SA (GSZ FP): The owner of Europe’s biggest natural-gas network had its share-price estimate cut to 37 euros from 39 euros at Sal. Oppenheim Jr. & Cie. The brokerage kept a “buy” recommendation. The shares fell 25 cents, or 0.8 percent, to 29.59 euros.

Ingenico SA (ING FP): Bank of America increased its price estimate for the world’s largest maker of payment terminals to 21 euros from 17.5 euros. The brokerage reiterated a “buy” recommendation. The shares gained 81.5 cents, or 5 percent, to 17.07 euros.

L’Oreal SA (OR FP): The world’s largest cosmetics maker plans to expand in emerging markets such as the Middle East and Africa, newspaper Investir reported, citing an interview with Chief Executive Officer Jean-Paul Agon.

ING Groep NV downgraded L’Oreal to “sell” from “hold,” saying “it’s time to take profits.” The stock rallied 4.81 euros, or 7.4 percent, at 69.50 euros.

Riber SA (RIB FP): The maker of machines to produce semiconductor wafers said it’s aiming to report a full-year profit after narrowing its net loss to 360,000 euros in the first half. The stock rose 7 cents, or 5.7 percent, to 1.31 euros.

Sanofi-Aventis SA (SAN FP): The pharmaceutical company’s experimental anti-clotting drug prevented deaths and cardiac complications in people with mild heart attacks and severe chest pain better than standard treatment, a study found. The shares climbed 75 cents, or 1.6 percent, to 48.17 euros.

Sopra Group SA (SOP FP): The French computer consultant said first-half net income fell to 10.8 million euros from 24.7 million euros a year earlier. The shares rose 34 cents, or 1 percent, to 34.40 euros.

Total SA (FP FP): France’s largest oil producer will keep a crude-distillation unit at its Gonfreville refinery shut until mid-September because of weak fuel demand, Paris Normandie reported, citing Gerard Roussel, head of the refinery. The shares added 11 cents, or 0.3 percent, at 40.31 euros.

Wendel (MF FP): Europe’s third-largest publicly listed private-equity firm reported a first-half net loss of 958.9 million euros after it was hurt by the dilution of its stake in Cie. de Saint-Gobain SA. The shares climbed 1.30 euros, or 3.8 percent, to 35.42 euros.

To contact the reporter on this story: Anne-Sylvaine Chassany in Paris at achassany@bloomberg.net. Francesca Cinelli in Milan at fcinelli@bloomberg.net





Read more...

AstraZeneca Drug Reduces Heart Attacks More Than Sanofi Rival

By Michelle Fay Cortez

Aug. 31 (Bloomberg) -- AstraZeneca Plc’s experimental clot- fighting drug Brilinta prevented 16 percent more heart attacks, strokes and deaths than standard therapy with Sanofi-Aventis SA’s and Bristol-Myers Squibb Co.’s Plavix in a study.

Brilinta’s potency didn’t cause more episodes of serious bleeding, a common complication seen with drugs that ward off heart conditions by preventing blood clots from developing, the research showed. The findings position Brilinta to rival Plavix, the second-biggest selling medicine in the world with almost $10 billion in annual revenue, for millions of patients suffering from heart attacks or severe chest pain.

About 1.3 million Americans are hospitalized each year with heart attacks and chest pain known as acute coronary syndromes. While aspirin and Plavix have lowered their subsequent health risks, cardiovascular disease remains the leading cause of death worldwide. Death from any cause was also significantly lower in patients taking Brilinta, according to the results of the study known as Plato.

“I think this will become the new standard of care,” said Douglas Weaver, a cardiologist at Henry Ford Hospital in Detroit and a past president of the American College of Cardiology, in an interview. “It’s more rapid, more effective and it appears to be safer” than Plavix and another competitor, Effient, from Eli Lilly & Co. of Indianapolis and Daiichi Sankyo Co. of Japan. “I don’t think they could have done much better than they did in this trial.”

North America

The study included more than 18,000 patients in 43 countries. Those in North America may have done worse on Brilinta, a finding researchers couldn’t explain. That raised questions among analysts about future sales in the U.S.

“The North American market is such a big issue in terms of sales,” said Michael Leacock, an analyst at Royal Bank of Scotland in London. “This North American subgroup leaves a little more room for debate.”

While analyst estimates are sure to rise for Brilinta’s sales, it might not be enough to make the company’s shares more attractive, Leacock said in an interview. AstraZeneca faces lower-priced competition on products that generate 62 percent of sales by 2014.

“It certainly seems to be a more competitive product than we would have expected,” Leacock said. “The consensus is already at $1 billion a year. Even if you add another $1 billion to AstraZeneca’s sales in 2013, I’m not sure it makes a large difference to the investment case for AstraZeneca.”

AstraZeneca shares have gained 1.2 percent this year, compared with a 2.1 percent increase in the 17-member Bloomberg Europe Pharmaceutical Index. Sanofi, which is set to lose patent protection on Plavix in 2011, has risen 6.1 percent.

Eagerly Anticipated

The trial, funded by London-based AstraZeneca, was one of the most eagerly anticipated findings presented at the European Society of Cardiology meeting in Barcelona this week. It was simultaneously published in the New England Journal of Medicine yesterday. The researchers reported an unexpected 22 percent reduction in the overall risk of early death from any cause.

“Bristol-Myers Squibb and Sanofi-Aventis have not had an opportunity to fully analyze the results of Plato,” Laura Hortas, a spokeswoman for New York-based Bristol-Myers, said yesterday in an e-mail. Plavix is approved for use in a broad group of patients with cardiovascular conditions, while the Brilinta trial focused only on patients who suffer from acute coronary syndromes including heart attacks and chest pain, Hortas said.

Seeking Approval

The U.K. drugmaker plans to file for approval of Brilinta in the fourth quarter in Europe and the U.S. and hopes to begin selling it next year, said Gunnar Olsson, AstraZeneca’s head of cardiovascular therapy.

Brilinta, Plavix and Effient all work by preventing platelets from clumping together in the blood to form clots. Plavix and Effient, which was approved this year in Europe and the U.S., last for the life of the platelet, or about a week, and are given once a day. Brilinta needs to be taken twice daily, and patients are likely to comply with that regimen, said David Snow, AstraZeneca’s vice president of cardiovascular global marketing.

“You’ve had a heart attack,” Snow said in an interview in Barcelona. “You’re certainly going to be motivated to avoid another one.”

About 30 percent of patients don’t respond well to Plavix. Brilinta’s effects wear off in a few days, making surgery easier for patients who need it.

‘Huge Conundrum’

One in 10 patients rushed to the hospital with chest pain or heart attacks actually need by-pass surgery, said Christopher Cannon, a cardiologist at Brigham and Women’s Hospital in Boston. If they are given Plavix or Effient, they must wait five days before getting the surgery, he said.

“It’s a huge conundrum, a headache for doctors, hospitals and patients,” he said in a telephone interview. “This opens the door. It’s a neat differentiating factor that could open up treatment options.”

In the study, 9.8 percent of patients taking Brilinta for a year after being treated for a heart attack or worsening chest pain suffered another heart attack or stroke, or died from vascular disease, compared with 11.7 percent of those given Plavix. Overall, 4.5 percent of Brilinta patients died from any cause, significantly fewer than the 5.9 percent of Plavix patients who died.

Major Bleeding

The rates of major bleeding were similar between the two groups, occurring in 11.6 percent of those on Brilinta and 11.2 percent of those on Plavix. Fatal bleeding in the brain was more frequent in those given Brilinta, while fatal bleeding in other areas was more common with Plavix. Brilinta was linked to more serious bleeding in the brain and stomach of patients who didn’t undergo bypass surgery, the study found.

“You have to keep the big picture,” said Jay Horrow, AstraZeneca’s executive director of clinical development. “Ticagrelor had fewer patients with fatal bleeding overall than clopidogrel.”

To contact the reporter on this story: Michelle Fay Cortez in London at mcortez@bloomberg.net





Read more...

Airgas, Bristol-Myers, Ford, Pacer, Watson: U.S. Equity Preview

By Lu Wang

Aug. 31 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses.

Airgas Inc. (ARG US): The biggest U.S. distributor of industrial gases will replace Cooper Industries Ltd. (CBE US) in the Standard & Poor’s 500 Index, S&P said in a statement.

Bristol-Myers Squibb Co. (BMY US): AstraZeneca Plc’s (AZN US) experimental clot-fighting drug Brilinta prevented 16 percent more heart attacks, strokes and deaths than standard therapy with Sanofi-Aventis SA’s (SNY US) and Bristol-Myers Squibb’s Plavix in a study.

Broadcom Corp. (BRCM US): The maker of semiconductors for wireless headsets and television set-top boxes said in entered a partial settlement of shareholder derivative lawsuits. Broadcom said it would receive about $118 million from directors and officers liability insurers, if the settlement is approved.

Expeditors International of Washington Inc. (EXPD US): The company that buys and resells bulk cargo space on ships and planes may rise 20 percent or more as the global economy recovers, Barron’s said.

Ford Motor Co. (F US): The company, seeking labor concessions granted to U.S. rivals, is working to bridge a gap with the United Auto Workers amid union resistance to a second round of 2009 givebacks, people familiar with the talks said.

Johnson Controls Inc. (JCI US): The largest U.S. auto-parts supplier may rise as increasing demand for energy-efficient cars and buildings boosts its earnings, Barron’s said, citing analysts.

Hillenbrand Inc. (HI US): The largest U.S. maker of coffins may rise as the economy rebounds and consumers spend more on funerals and cremation products, Barron’s said, citing analysts.

Pacer International Inc. (PACR US): The provider of trucking, freight and transportation logistics services said it entered into an amended and restated credit agreement with its syndicate of financial institutions.

Tessera Technologies Inc. (TSRA US): The designer of packaging for computer chips lost a U.S. trade ruling in its efforts to get new licensing revenue from makers of computer- memory chips.

Watson Pharmaceuticals Inc. (WPI US): The drugmaker said it received approval from the U.S. Food and Drug Administration on its abbreviated new drug application for Levonorgestrel day- after contraceptive tablets for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.

To contact the reporter on this story: Lu Wang in New York at lwang8@bloomberg.net.





Read more...